Breaking News

Sterling Pharma Solutions Acquires Novartis Facility

The CDMO expands its global API manufacturing capabilities with the purchase of the site in Ringaskiddy, Ireland.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), reached agreement with Novartis to acquire its Ringaskiddy campus (Novartis Ringaskiddy Limited), near Cork, Ireland. Financial details of the sale, which is expected to close in Q4, 2022, have not been disclosed. Sterling will acquire the 111-acre site, which includes three active pharmaceutical ingredient (API) manufacturing buildings, as well as facilities to support development and scale up in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters